Biotech

Benitec Limited (ASX:BLT) Chairman Address to 2010 Annual General Meeting

🕔11/26/2010 11:13:24 AM

Benitec Limited (ASX:BLT) (PINK:BNIKF) is pleased to release Chairman address to 2010 Annual General Meeting.

Read Full Article▸

Mesoblast Limited (ASX:MSB) Clear To Proceed With Angioblast Acquisition

🕔11/19/2010 2:47:27 PM

Australian regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that the required period for any antitrust objection under the United States Hart-Scott-Rodino(HSR) anti-trust improvement Act 1976 in respect of its acquisition of Angioblast Systems Inc. has expired.

Read Full Article▸

Mesoblast Limited (ASX:MSB) Announce Positive Results Of Novel Heart Attack Treatment Presented At Premier USA Cardiology Conference

🕔11/16/2010 10:06:38 AM

Regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) announced that positive preclinical trial results were today presented at the American Heart Association's annual conference in Chicago showing that the company's proprietary allogeneic stem cells can be injected simply, safely, and effectively into the coronary arteries after a heart attack to prevent heart failure.

Read Full Article▸

Mesoblast Limited (ASX:MSB) Awarded U.S. Government Grants For Further Development of Adult Stem Cell Products

🕔11/8/2010 10:18:56 AM

Regenerative medicine company, Mesoblast Limited (ASX:MSB) (USOTC:MBLTY), today announced that its United States associate company, Angioblast Systems, has been awarded $1.2 million in grants under the United States Government's Qualifying Therapeutic Discovery Project (QTDP) program.

Read Full Article▸

Benitec Limited (ASX:BLT) Received Key Patent Notice of Intent To Re-Issue In the USA

🕔11/8/2010 10:14:17 AM

Benitec Limited (ASX:BLT) (PINK:BNIKF), the , the leading company in expressed gene silencing for human therapeutics, announced today that the United States Patent and Trademark Office (USPTO) has issued an official Notice of Intent to Issue an Ex Parte Re-examination Certificate for US Patent 6,573,099 ("the '099 Graham Patent"), the wide-ranging platform technology patent covering the use of expressed RNAi in human therapeutic applications.

Read Full Article▸

Benitec Limited (ASX:BLT) UK Patent Update

🕔11/5/2010 5:40:11 PM

Benitec Limited (ASX:BLT) (PINK:BNIKF), the leading company in expressed gene silencing for human therapeutics, announced today that it has been notified overnight by UK patent attorneys that the United Kingdom Intellectual Property Office (UKIPO) has received an application to revoke Benitec's exclusively licensed patent UK Patent no. 2,353,282. The application to revoke was filed by a UK-based patent attorney firm, which may be acting on behalf of a third party who are not disclosed in the application.

Read Full Article▸

Benitec Limited (ASX:BLT) Cash Flow Update For The Quarter Ended 30 September 2010

🕔10/29/2010 11:33:52 AM

Benitec Limited (ASX:BLT) (PINK:BNIKF) has lodged its Statement of Cash Flows for the quarter ended 30 September 2010, showing operating cash outflows of $615,000 and cash at the end of the quarter of $556,000. During the quarter, the Company received funding from the convertible note facility with La Jolla Cove Investors, Inc of $548,000.

Read Full Article▸

Banking & Finance

Read More

Oil Gas & Energy

Read More

Life Sciences

Read More

Social Media

Latest Headlines